Deadline: 12 April 2017
The Small Business Research Initiative (SBRI) in partnership with the Department of Health and the Medical Research Council, is currently seeking applications from the eligible organisations for developing of vaccines for global epidemics.
This competition aims to support the clinical development of candidate vaccines against 12 diseases. The UK Vaccine Network has identified these diseases as a priority because they have the potential to cause epidemics in low- and middle-income countries (LMICs).
The competition is a single stage. It covers carrying out clinical development of vaccines up to and including phase IIb trials.
Priority Areas
This competition will support projects seeking to develop candidate vaccines and vaccine platform technologies at the clinical stage. The aim is to enable an effective and rapid response during future outbreaks of disease. The UK Vaccine Network has identified 12 pathogens as a priority:
- chikungunya
- Crimean-Congo haemorrhagic fever
- ebola
- hantavirus
- lassa fever
- Marburg virus
- Middle East respiratory syndrome
- nipah
- plague
- Q fever
- Rift Valley fever
- zika
Funding Information
It is expected that individual contracts will be valued up to £3 million. Projects should last between 24 and 36 months.
Eligibility Criteria
This competition is open to academic, industry and government bodies. One must demonstrate that their product has a realistic route to exploitation. However, it is recognised that this is a complex procedure, given the priority diseases listed.
How to Apply
Eligible entities must apply online via given website.
Eligible Countries
Afghanistan, Albania, Algeria, American Samoa, Angola, Armenia, Azerbaijan, Bangladesh, Belarus, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Cape Verde, Central African Republic, Chad, China, Colombia, Comoros, Congo, Congo, Rep., Costa Rica, Côte d’Ivoire, Cuba, Djibouti, Dominica, Dominican Republic , Ecuador, Egypt, El Salvador, Eritrea, Ethiopia, Fiji, Gabon, Gambia, Georgia, Ghana, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, India, Indonesia, Iran, Iraq, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Korea, Kosovo, Kyrgyz Republic, Lao PDR, Lebanon, Lesotho, Liberia, Libya, Macedonia, Madagascar, Malawi, Malaysia, Maldives, Mali, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia, Moldova, Mongolia, Montenegro. Morocco, Mozambique, Myanmar, Namibia, Nepal, Nicaragua, Niger, Nigeria, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Romania, Rwanda, Samoa, São Tomé and Principe, Senegal, Serbia, Sierra Leone, Solomon Islands, Somalia, South Africa, South Sudan, Sri Lanka, St. Lucia, St. Vincent and the Grenadines, Sudan, Suriname, Swaziland, Syrian, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, Uzbekistan, Vanuatu, Vietnam, West Bank and Gaza, Yemen, Zambia, Zimbabwe.
For more information, please visit this link.
